As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and Drug Administration (FDA).

Red, inflamed skin is one of the symptoms of psoriasis. Beyond the symptoms of this skin condition, people with psoriasis might also be at risk for other major problems, including cancer.

Research into treating breast cancer may have also stumbled onto a way to treat psoriasis. The two conditions share a protein that, if blocked, may reduce the intensity of both diseases.

A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.